NANJING LEADS BIOLABS CO LTD has a total of 15 patent applications. Its first patent ever was published in 2018. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and China. Its main competitors in its focus markets pharmaceuticals and biotechnology are PIERIS AUSTRALIA PTY LTD, ABEXXA BIOLOGICS INC and ELSTAR THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | United States | 4 | |
#3 | China | 3 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Huang Xiao | 15 |
#2 | Kang Xiaoqiang | 15 |
#3 | Lai Shoupeng | 11 |
#4 | Zhou Lijun | 4 |
#5 | Sun Jianming | 2 |
Publication | Filing date | Title |
---|---|---|
US2021115142A1 | Recombinant protein targeting pd-1 and tgfβ | |
WO2021068841A1 | Antibodies binding 4-1bb and uses thereof | |
WO2019219064A1 | Antibody binding pd-1 and use thereof | |
CN111989341A | TIM-3 binding antibodies and uses thereof | |
US2019016800A1 | Antibodies binding LAG-3 and uses thereof |